Tools · LLY
Eli Lilly and Company, taken apart.
Four panels built from the reported annual accounts, then the rest of the engine. Every figure below is Eli Lilly and Company’s own filing, not an estimate of ours.
Income statement
Revenue mix
Peer comparison
Analyst ratings
What if I had bought
Sentiment
Chart patterns
What the analysts say
The published view, for contrast with ours. The source gives a consensus and a target range rather than a full buy/hold/sell breakdown, so that is what is shown — and it is why the grade scores analyst upside rather than counting recommendations.
| Published figure | Position | Detail |
|---|---|---|
| Consensus: Buy | 29 analysts | |
| Mean target: $1,315.04 | 62% of range | |
| High target: $1,600.00 | 100% of range | |
| Low target: $850.00 | 0% of range |
29 analysts cover it, and their targets run from $850.00 to $1,600.00 — a spread of 88%, with the mean 4.7% above today's price. A consensus is an average of disagreement, not a forecast.
The rest of the engine
The panels above are built from filings. These run against the live engine.
/screener
Screener
Preset screens run against the live universe
Value, growth, quality and momentum presets
/markets
Markets
Indices, sector performance and the yield curve
One request per panel, cached for ten minutes
/dcf-calculator
DCF calculator
Value the company on the cash it produces
The projection period and terminal growth are yours
/watchlist
Watchlist
Follow symbols with a live price and day change
Needs an account
/portfolio
Portfolio
Holdings with unrealised profit and loss
Totalled per currency — needs an account
/learn
Learn
Guides, a glossary and the assistant
Explains the scorecard this site actually runs